ER+/HER2 positive breast cancer research hub

A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

This study is looking at a new medicine for ER+/HER2 positive breast cancer. Researchers want to see if this new medicine, called vepdegestrant, affects how your body handles another medicine, midazolam, which is often used during medical procedures.

A Study to Estimate the Effect of Multiple Doses of Carbamazepine on the PK of Single Dose Vepdegestrant in Healthy Adult Participants